Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,273,121
-$37,539,876 QoQ
Shares Held
269,587
-80.4% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. VRDN ranks #96 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in VRDN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,273,121 | 269,587 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $42,812,997 | 1,375,739 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $18,757,077 | 869,188 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $16,886,036 | 1,207,871 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $14,612,859 | 1,084,040 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $15,579,177 | 684,799 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $949,391 | 72,974 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,378,054 | 78,701 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $6,562,074 | 301,289 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $14,764,642 | 962,493 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $15,491,548 | 651,179 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $16,009,900 | 629,320 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $17,860,658 | 611,457 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $12,483,657 | 608,662 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $5,146,323 | 444,799 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $324,739 | 17,563 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $1,747,766 | 88,405 | Shares | Other | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||